Establishment Labs Holdings Inc. (ESTA) vs NovoCure Limited (NVCR)
Establishment Labs Holdings Inc. and NovoCure Limited are both Medical Devices companies. Establishment Labs Holdings Inc. and NovoCure Limited are of similar size ($2.0B and $1.9B). Establishment Labs Holdings Inc. grew revenue faster over the last twelve months: 38.6% against 11.0%. Establishment Labs Holdings Inc. has the higher net margin (−15.8% vs −21.3%) and the higher return on invested capital (−5.53% vs −115.6%). Across the 18 metrics below, Establishment Labs Holdings Inc. leads on 10 and NovoCure Limited on 8.
Valuation
Profitability
| Metric | ESTA | NVCR | Medical Devices median |
|---|---|---|---|
| Gross margin | 70.49% | 76.13% | 56.01% |
| Operating margin | (7.63%) | (22.08%) | (15.03%) |
| Net margin | (15.82%) | (21.25%) | (20.40%) |
| Free cash flow margin | (16.90%) | (3.64%) | (7.24%) |
| Return on equity | (175.30%) | (43.22%) | (15.32%) |
| Return on assets | (11.41%) | (14.56%) | (19.72%) |
| Return on invested capital | (5.53%) | (115.56%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack